Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457756 · ClinicalTrials.gov registry record · NA
The Effect of BiosLife on Serum Lipids
A NA study of Hypercholesterolemia, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT00457756: Completed NA study of Hypercholesterolemia, sponsored by University of Utah.
NCT00457756 is a NA study of Hypercholesterolemia that has completed, run by University of Utah. The registered enrollment target is 100 participants, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00457756, a NA study of Hypercholesterolemia, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a double-blind, placebo-controlled study to assess the effectiveness of BiosLife in lowering serum LDL cholesterol and raising HDL cholesterol. BiosLife is a natural supplement (mixed in water and taken twice daily) which contains guar gum and other natural soluble fibers, phytosterols, policosanol, and a proprietary chrysanthemum extract. Approximately 100 subjects with baseline LDL cholesterol of 110-190 mg/dL will be randomized in a 2:1 ratio to BiosLife or a look-alike placebo. Changes in lipids from baseline will be assessed at 6 weeks and 12 weeks.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT BiosLife Complete
Study Locations (1)
Utah
- Cardiovascular Genetics, University of Utah, 420 Chipeta Way, Room 1160 - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-07 |
| Phase | NA |
What the finished NCT00457756 record still lists
NCT00457756 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00457756 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT00457756 about?
NCT00457756 is a clinical study titled "The Effect of BiosLife on Serum Lipids". This is a double-blind, placebo-controlled study to assess the effectiveness of BiosLife in lowering serum LDL cholesterol and raising HDL cholesterol. BiosLife is a natural supplement (mixed in water and taken twice daily) which contains guar gum and other natural soluble fibers, phytosterols, poli...
What is the current status of trial NCT00457756?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2007-01. Estimated completion is 2007-07.
What conditions does trial NCT00457756 study?
This clinical trial studies the following conditions: Hypercholesterolemia.
What interventions are being tested in trial NCT00457756?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), BiosLife Complete (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00457756?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00457756 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00457756's enrollment target sits among peer trials
100 39th of 62 higher than 24 of 62 other Hypercholesterolemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypercholesterolemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
RECRUITING · NA
-
Pharmacogenomic Informed Statin Prescribing
RECRUITING · NA
-
A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
ACTIVE NOT RECRUITING · NA
-
Effect of Diabetes Mellitus on Cholesterol Metabolism
COMPLETED · NA
-
Evaluating the Efficacy of Pediatric Lipid Screening Alerts
COMPLETED · NA
-
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia